Akathisia is seen with the use of:
First, the core concept is about extrapyramidal side effects of antipsychotics. Akathisia is a movement disorder characterized by restlessness and an inability to sit still. It's a known side effect of dopamine receptor antagonists, especially first-generation antipsychotics like haloperidol or chlorpromazine. The mechanism involves blockade of dopamine D2 receptors in the basal ganglia pathways.
Now, the correct answer would be one of these antipsychotics. Let's say the options were, for example, Haloperidol, Fluoxetine, Diazepam, and Risperidone. The correct answer would be Haloperidol.
For each wrong option: Fluoxetine is an SSRI, not associated with akathisia. Diazepam is a benzodiazepine, which might cause sedation but not akathisia. Risperidone, a second-gen antipsychotic, can cause EPS but is less likely than first-gen drugs. However, it's possible if the question is about both classes.
Clinical pearl: Remember that first-gen antipsychotics have higher risk of EPS, including akathisia, due to more potent D2 blockade. Second-gen drugs have lower risk but can still cause it. Anticholinergics like benztropine are used for treatment.
Putting it all together, the explanation should cover the mechanism, why the correct drug is right, and why others are not. Need to make sure the sections are properly labeled and within the character limit.
**Core Concept**
Akathisia is an extrapyramidal side effect caused by dopamine D2 receptor blockade in the nigrostriatal pathway, commonly associated with antipsychotic medications. First-generation (typical) antipsychotics like haloperidol are classic culprits due to their high D2 receptor affinity.
**Why the Correct Answer is Right**
Haloperidol, a first-generation antipsychotic, blocks dopamine D2 receptors in the basal ganglia, disrupting motor control circuits. This leads to akathisia, characterized by subjective restlessness and compulsive movement. The nigrostriatal pathwayβs role in motor coordination makes it particularly vulnerable to D2 antagonism.
**Why Each Wrong Option is Incorrect**
**Option A:** Fluoxetine (SSRI) β Causes akathisia rarely, but itβs a second-line mechanism compared to antipsychotics.
**Option B:** Diazepam (benzodiazepine) β Reduces anxiety but does not induce extrapyramidal symptoms.
**Option C:** Risperidone (atypical antipsychotic) β May cause akathisia but at lower rates than first-generation agents due to partial D2 agonism.
**Clinical Pearl / High-Yield Fact**
Remember: *"EPS with antipsychotics β D2 is the key!"* First-generation antipsychotics (e.g., haloperidol) have a higher EPS risk than second-generation drugs (e.g., risperidone, olanzapine). Anticholinerg